Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Testing for Rheumatological Diagnoses in Children.

Smith JA.

Eur Paediatr Rev. 2009;3(1):30-34.

2.

Clinical utility of antinuclear antibody tests in children.

McGhee JL, Kickingbird LM, Jarvis JN.

BMC Pediatr. 2004 Jul 9;4:13. Review.

3.

Antinuclear antibody testing. A study of clinical utility.

Slater CA, Davis RB, Shmerling RH.

Arch Intern Med. 1996 Jul 8;156(13):1421-5.

PMID:
8678710
4.

How useful is the rheumatoid factor? An analysis of sensitivity, specificity, and predictive value.

Shmerling RH, Delbanco TL.

Arch Intern Med. 1992 Dec;152(12):2417-20.

PMID:
1456851
5.

Determination of anti-cyclic citrullinated peptide antibodies in the sera of patients with juvenile idiopathic arthritis.

Low JM, Chauhan AK, Kietz DA, Daud U, Pepmueller PH, Moore TL.

J Rheumatol. 2004 Sep;31(9):1829-33.

PMID:
15338508
6.

Utilization and predictive value of laboratory tests in patients referred to rheumatologists by primary care physicians.

Suarez-Almazor ME, Gonzalez-Lopez L, Gamez-Nava JI, Belseck E, Kendall CJ, Davis P.

J Rheumatol. 1998 Oct;25(10):1980-5.

PMID:
9779854
7.

The rheumatoid factor: an analysis of clinical utility.

Shmerling RH, Delbanco TL.

Am J Med. 1991 Nov;91(5):528-34. Review.

PMID:
1951415
8.

Clinical utility of common serum rheumatologic tests.

Lane SK, Gravel JW Jr.

Am Fam Physician. 2002 Mar 15;65(6):1073-80.

10.

Evaluating inflammatory joint disease: how and when can autoantibodies help?

Meyer O.

Joint Bone Spine. 2003 Dec;70(6):433-47.

PMID:
14667551
11.

Evidence of fibrinogen as a target of citrullination in IgM rheumatoid factor-positive polyarticular juvenile idiopathic arthritis.

Gilliam BE, Reed MR, Chauhan AK, Dehlendorf AB, Moore TL.

Pediatr Rheumatol Online J. 2011 Mar 25;9:8. doi: 10.1186/1546-0096-9-8.

12.

Antinuclear Antibody, Rheumatoid Factor, and Cyclic-Citrullinated Peptide Tests for Evaluating Musculoskeletal Complaints in Children [Internet].

Wong KO, Bond K, Homik J, Ellsworth JE, Karkhaneh M, Ha C, Dryden DM.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2012 Mar.

13.

Modelling autoimmune rheumatic disease: a likelihood rationale.

Ulvestad E.

Scand J Immunol. 2003 Jul;58(1):106-11.

14.
15.

Anti-cyclic citrullinated peptide antibodies in patients with juvenile idiopathic arthritis.

Habib HM, Mosaad YM, Youssef HM.

Immunol Invest. 2008;37(8):849-57. doi: 10.1080/08820130802438057.

PMID:
18991100
16.

The significance of rheumatoid factor and anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus.

Popescu C, Zofotă S, Bojincă V, Ionescu R.

Rom J Intern Med. 2013 Jul-Dec;51(3-4):179-87.

PMID:
24620631
17.

Clinical utility of screening for antinuclear antibodies by enzyme immunoassay--a preliminary study.

Divate S, Hardikar P, Bichile LS, Rajadhyaksha A.

J Assoc Physicians India. 2004 Apr;52:290-3.

PMID:
15636329
18.

The diagnostic utility of the anti-CCP antibody test is no better than rheumatoid factor in South Africans with early rheumatoid arthritis.

Hodkinson B, Meyer PW, Musenge E, Ally MM, Wadee AA, Anderson R, Tikly M.

Clin Rheumatol. 2010 Jun;29(6):615-8. doi: 10.1007/s10067-010-1374-x. Epub 2010 Feb 2.

PMID:
20127131
19.

Prevalence and patterns of anti-nuclear antibodies in Korean children with juvenile idiopathic arthritis according to ILAR criteria.

Shin JI, Kim KH, Chun JK, Lee TJ, Kim KJ, Kim HS, Kim DS.

Scand J Rheumatol. 2008 Sep-Oct;37(5):348-51. doi: 10.1080/03009740801998762.

PMID:
18666025
20.

The clinical utility of a positive antinuclear antibody test result.

Abeles AM, Abeles M.

Am J Med. 2013 Apr;126(4):342-8. doi: 10.1016/j.amjmed.2012.09.014. Epub 2013 Feb 8.

PMID:
23395534
Items per page

Supplemental Content

Write to the Help Desk